Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Rubin

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Bioconjugate Chemistry|May 29, 1999
Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and propertiesD L Ladd, R Hollister, X Peng, et al.
AJNR. American Journal of Neuroradiology|January 9, 2016
Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary GlioblastomasT T Liu, A S Achrol, L A Mitchell, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 6, 1997
A multicenter clinical trial of Gadolite Oral Suspension as a contrast agent for MRID L Rubin, K L Falk, M J Sperling, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|November 13, 2008
BioPortal: ontologies and data resources with the click of a mouseM A Musen, Mark Musen, N H Shah, et al.
Investigative Radiology|July 20, 2000
Magnetic resonance imaging in patients with central nervous system pathology: a comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA)R I Grossman, D L Rubin, G Hunter, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 26, 2000
Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imagingM Federle, J Chezmar, D L Rubin, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 10, 1999
A multisite phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvisW C Small, D DeSimone-Macchi, J R Parker, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 10, 2000
Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety)M P Federle, J L Chezmar, D L Rubin, et al.
Physical Review Letters|November 5, 2023
Measurement of the Positive Muon Anomalous Magnetic Moment to 0.20 ppmD P Aguillard, T Albahri, D Allspach, et al.
Physical Review Letters|September 22, 2025
Measurement of the Positive Muon Anomalous Magnetic Moment to 127 ppbD P Aguillard, T Albahri, D Allspach, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Bioconjugate Chemistry|May 29, 1999
Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and propertiesD L Ladd, R Hollister, X Peng, et al.
AJNR. American Journal of Neuroradiology|January 9, 2016
Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary GlioblastomasT T Liu, A S Achrol, L A Mitchell, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 6, 1997
A multicenter clinical trial of Gadolite Oral Suspension as a contrast agent for MRID L Rubin, K L Falk, M J Sperling, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|November 13, 2008
BioPortal: ontologies and data resources with the click of a mouseM A Musen, Mark Musen, N H Shah, et al.
Investigative Radiology|July 20, 2000
Magnetic resonance imaging in patients with central nervous system pathology: a comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA)R I Grossman, D L Rubin, G Hunter, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 26, 2000
Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imagingM Federle, J Chezmar, D L Rubin, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 10, 1999
A multisite phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvisW C Small, D DeSimone-Macchi, J R Parker, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 10, 2000
Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety)M P Federle, J L Chezmar, D L Rubin, et al.
Physical Review Letters|November 5, 2023
Measurement of the Positive Muon Anomalous Magnetic Moment to 0.20 ppmD P Aguillard, T Albahri, D Allspach, et al.
Physical Review Letters|September 22, 2025
Measurement of the Positive Muon Anomalous Magnetic Moment to 127 ppbD P Aguillard, T Albahri, D Allspach, et al.
Pageof 6